NCT00005905View on ClinicalTrials.gov

Leptin to Treat Lipodystrophy

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2000

Study Completion Date

April 30, 2003

Conditions
Lipodystrophy
Interventions
DRUG

hu Leptin (A-100)

Trial Locations (1)

20892

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00005905 - Leptin to Treat Lipodystrophy | Biotech Hunter | Biotech Hunter